New drug tested to help pulmonary hypertension patients breathe easier during activity
NCT ID NCT06409026
Summary
This study is testing whether the drug sotatercept, taken for 36 weeks, improves how the heart and lungs work together during exercise in people with pulmonary arterial hypertension. Researchers will measure heart function, blood flow, and oxygen delivery in 30 participants while they exercise. The goal is to see if the drug helps patients feel better and be more active by improving their body's ability to handle physical activity.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.